MTOR and cancer: Knockdown of mTOR in LAL deficient MDSCs suppressed their stimulation on proliferation of several cancer lineages, including B16 melanoma, Lewis lung carcinoma and transgenic mouse prostate cancer-C2 cancer cells [67].